Search
Friday 25 September 2015
  • :
  • :
Latest Update

Stocks on Trader’s Radar - RR Donnelley & Sons Co(NASDAQ:RRD), KBR, Inc.(NYSE:KBR), Vitae Pharmaceuticals Inc(NASDAQ:VTAE), AFLAC Incorporated(NYSE:AFL)

On Monday, RR Donnelley & Sons Co(NASDAQ:RRD)’s shares declined -2.09% to $15.43.

RR. Donnelley & Sons Company (RRD) declared that it has published the fourth edition of its complimentary “Guide to Effective Proxies” designed to assist organizations in optimizing their shareholder communications as they work to transform proxy statements from traditional compliance documents to more compelling shareholder communication pieces.

The Guide features a large selection of styles, devices and formats to aid companies in the complete design and development of proxy statements that proactively engage investors while meeting the company’s proxy-related objectives and strict regulatory requirements. The Guide represents a unique tool that reflects how leading companies recently are communicating their proxy stories and how new trends in formats and features are influencing investor expectations.

R.R. Donnelley & Sons Company provides integrated communications solutions to private and public sector clients in the United States and internationally. The company operates through Publishing and Retail Services, Variable Print, Planned Services, and International segments. I

KBR, Inc.(NYSE:KBR)’s shares dropped -0.03% to $16.90.

KBR, Inc. (KBR) declared it has been awarded a prime contractor position for a multiple award indefinite-delivery/indefinite quantity (IDIQ) contract by the U.S. Air Force for base life support and logistics and construction services worldwide.

KBR is one of eight companies awarded a prime contractor position to compete for specific task orders on the $5B Air Force Contract Augmentation Program (AFCAP IV).

AFCAP IV, awarded by the 772nd Enterprise Sourcing Squadron, Air Force Installation Contracting Agency at Tyndall Air Force Base in Florida, will provide base life and operating support, logistics support, and construction services as needed to support the Air Force, Department of Defense, or any U.S. federal government entity performing contingency operations. Work will be performed at locations worldwide to be determined by individual needs. This work is predictable to be performed over seven years, with funding allocated to orders on an as-required basis in support of the AFCAP scope of services.

KBR, Inc. operates as an engineering, construction, and services company worldwide. The company operates through three segments: Technology & Consulting, Engineering & Construction, and Government Services. The Technology & Consulting segment offers various services and solutions, counting licensing, engineering and design, proprietary equipment, plant automation, catalysts, and related consulting services to hydrocarbons, chemicals, and fertilizer markets.

At the end of Monday’s trade, Vitae Pharmaceuticals Inc(NASDAQ:VTAE)‘s shares surged 4.22% to $15.31.

Vitae Pharmaceuticals, Inc. (VTAE), a clinical-stage biotechnology company, recently declared that Jeff Hatfield, President and Chief Executive Officer, will ring the NASDAQ Closing Bell at the NASDAQ MarketSite in Times Square recently at 4:00 p.m. ET.

Mr. Hatfield will be joined by Vitae’s executive leadership team to recognize the one-year anniversary of the Company’s initia

Vitae Pharmaceuticals, Inc., a biotechnology company, focuses on discovering and developing novel and small molecule drugs for diseases with unmet medical needs in the United States.

AFLAC Incorporated(NYSE:AFL), ended its Monday’s trading session with 0.87% gain, and closed at $57.70.

As employers continue to load more health care expenses onto workers, more than half (53 percent) of employees are still choosing a major medical plan based on factors that may have little to do with the total cost of health care for which they are increasingly responsible. According to the 2015 Aflac Open Enrollment Survey released recently by Aflac (AFL), the leading provider of voluntary insurance at the work site in the United States, most workers (75 percent) at least somewhat agree that even with their health insurance coverage, their medical copays and other out-of-pocket costs are more than they can afford at times. In spite of this, however, a noteworthynumber of consumers lack the desire to research their insurance benefits.

The 2015 Aflac Open Enrollment Survey was conducted among 2,000 U.S. adults employed either full or part time in June and July 2015 by Lightspeed GMI on behalf of Aflac.

In fact, according to Aflac’s survey, many would rather do almost anything else than research their benefits:

  • More than a third (38 percent) would rather clean out their email inbox;
  • Nearly 1 in 4 (23 percent) would rather clean their toilet; and
  • 18 percent would rather do their taxes.

Aflac Incorporated, through its partner, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers various voluntary supplemental insurance products, counting cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *